Panagora Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-317
| Closed | -$214K | – | 1214 |
|
|
2025
Q4 | $214K | Hold |
317
| – | – | ﹤0.01% | 1101 |
|
|
2025
Q3 | $203K | Buy |
+317
| New | +$192K | ﹤0.01% | 1092 |
|
|
2024
Q4 | – | Sell |
-521
| Closed | -$263K | – | 1195 |
|
|
2024
Q3 | $263K | Hold |
521
| – | – | ﹤0.01% | 1075 |
|
|
2024
Q2 | $254K | Sell |
521
-961
| -65% | -$482K | ﹤0.01% | 1082 |
|
|
2024
Q1 | $800K | Sell |
1,482
-41
| -3% | -$22.4K | ﹤0.01% | 863 |
|
|
2023
Q4 | $845K | Buy |
1,523
+41
| +3% | +$19.2K | ﹤0.01% | 868 |
|
|
2023
Q3 | $648K | Hold |
1,482
| – | – | ﹤0.01% | 907 |
|
|
2023
Q2 | $744K | Hold |
1,482
| – | – | ﹤0.01% | 883 |
|
|
2023
Q1 | $741K | Sell |
1,482
-1,674
| -53% | -$801K | ﹤0.01% | 958 |
|
|
2022
Q4 | $1.29M | Sell |
3,156
-35
| -1% | -$13.6K | 0.01% | 784 |
|
|
2022
Q3 | $1.04M | Buy |
3,191
+62
| +2% | +$22.8K | 0.01% | 847 |
|
|
2022
Q2 | $1.1M | Sell |
3,129
-103
| -3% | -$42K | 0.01% | 845 |
|
|
2022
Q1 | $1.77M | Buy |
3,232
+1,081
| +50% | +$569K | 0.01% | 711 |
|
|
2021
Q4 | $1.42M | Sell |
2,151
-3,652
| -63% | -$2.29M | 0.01% | 774 |
|
|
2021
Q3 | $3.61M | Sell |
5,803
-40
| -0.7% | -$26.9K | 0.02% | 508 |
|
|
2021
Q2 | $3.69M | Buy |
5,843
+60
| +1% | +$33.1K | 0.02% | 516 |
|
|
2021
Q1 | $2.83M | Buy |
5,783
+3
| +0.1% | +$1.5K | 0.02% | 625 |
|
|
2020
Q4 | $2.89M | Sell |
5,780
-158
| -3% | -$70.7K | 0.02% | 568 |
|
|
2020
Q3 | $2.33M | Buy |
5,938
+40
| +0.7% | +$14.8K | 0.01% | 581 |
|
|
2020
Q2 | $1.95M | Sell |
5,898
-231
| -4% | -$66.9K | 0.01% | 681 |
|
|
2020
Q1 | $1.49M | Buy |
6,129
+98
| +2% | +$25.6K | 0.01% | 697 |
|
|
2019
Q4 | $1.57M | Sell |
6,031
-1,246
| -17% | -$328K | 0.01% | 884 |
|
|
2019
Q3 | $1.98M | Sell |
7,277
-29,443
| -80% | -$8.19M | 0.01% | 751 |
|
|
2019
Q2 | $10.1M | Sell |
36,720
-8,765
| -19% | -$2.16M | 0.05% | 337 |
|
|
2019
Q1 | $10.2M | Sell |
45,485
-154,022
| -77% | -$31.8M | 0.05% | 356 |
|
|
2018
Q4 | $37.1M | Sell |
199,507
-62,774
| -24% | -$12.9M | 0.17% | 138 |
|
|
2018
Q3 | $65.5M | Buy |
262,281
+124,742
| +91% | +$30.3M | 0.25% | 96 |
|
|
2018
Q2 | $30M | Buy |
137,539
+118,087
| +607% | +$24.3M | 0.12% | 182 |
|
|
2018
Q1 | $3.72M | Buy |
19,452
+9,926
| +104% | +$1.83M | 0.01% | 636 |
|
|
2017
Q4 | $1.49M | Buy |
9,526
+826
| +9% | +$130K | 0.01% | 995 |
|
|
2017
Q3 | $1.35M | Buy |
8,700
+854
| +11% | +$135K | 0.01% | 1008 |
|
|
2017
Q2 | $1.27M | Buy |
7,846
+939
| +14% | +$152K | 0.01% | 1023 |
|
|
2017
Q1 | $1.07M | Buy |
6,907
+219
| +3% | +$30.2K | ﹤0.01% | 1117 |
|
|
2016
Q4 | $784K | Sell |
6,688
-698
| -9% | -$79.7K | ﹤0.01% | 1282 |
|
|
2016
Q3 | $833K | Buy |
7,386
+620
| +9% | +$65.3K | ﹤0.01% | 1259 |
|
|
2016
Q2 | $628K | Sell |
6,766
-2,918
| -30% | -$251K | ﹤0.01% | 1296 |
|
|
2016
Q1 | $758K | Buy |
9,684
+4,402
| +83% | +$317K | ﹤0.01% | 1213 |
|
|
2015
Q4 | $385K | Hold |
5,282
| – | – | ﹤0.01% | 1402 |
|
|
2015
Q3 | $392K | Hold |
5,282
| – | – | ﹤0.01% | 1394 |
|
|
2015
Q2 | $339K | Hold |
5,282
| – | – | ﹤0.01% | 1477 |
|
|
2015
Q1 | $408K | Hold |
5,282
| – | – | ﹤0.01% | 1403 |
|
|
2014
Q4 | $392K | Hold |
5,282
| – | – | ﹤0.01% | 1372 |
|
|
2014
Q3 | $311K | Hold |
5,282
| – | – | ﹤0.01% | 1465 |
|
|
2014
Q2 | $353K | Hold |
5,282
| – | – | ﹤0.01% | 1516 |
|
|
2014
Q1 | $321K | Hold |
5,282
| – | – | ﹤0.01% | 1581 |
|
|
2013
Q4 | $281K | Sell |
5,282
-458
| -8% | -$24.1K | ﹤0.01% | 1557 |
|
|
2013
Q3 | $286K | Hold |
5,740
| – | – | ﹤0.01% | 1526 |
|
|
2013
Q2 | $258K | Buy |
+5,740
| New | +$251K | ﹤0.01% | 1519 |
|
Other funds holding IDXX
Panagora Asset Management's IDXX Position: Q1 2026 in Review
Panagora Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 317 shares — an estimated $214K sold.
Panagora Asset Management first reported a position in IDXX in Q2 2013 and held it in 48 quarters. The position peaked at $65.5M in Q3 2018. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Panagora Asset Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- Panagora Asset Management sold 317 Idexx Laboratories shares in Q1 2026, an estimated $214K.
- Panagora Asset Management first reported a position in Idexx Laboratories in Q2 2013 and held it in 48 quarters.
- Panagora Asset Management's Idexx Laboratories position peaked at $65.5M in Q3 2018.
- 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.